🇺🇸 FDA
Pipeline program

QGC001

QGC001/2QG1

Phase 2 small_molecule completed

Quick answer

QGC001 for Essential Hypertension is a Phase 2 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Quantum Biopharma
Indication
Essential Hypertension
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials